Concepedia

Author

C. Moriano

Marqués de Valdecilla University HospitalORCID

Also Known As

C Moriano, C. Moriano, Chiara Moriano, Clara Moriano, Clara Moriano Morales, Susana Romero-Yuste

125

Publications

509

Citations

12

H-Index

11

Concepts

All Affiliations

Marqués de Valdecilla University HospitalUniversidad de CantabriaInstituto de Investigación Marqués de ValdecillaComplejo Hospitalario de PontevedraHospital de Basurto
CM

About

C. Moriano is an author at Marqués de Valdecilla University Hospital specializing in immunology, autoimmune disease, and vasculitis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

147

2

Immunology

3

3

147

3

Pathology

2

2

122

4

Neurology

1

1

17

5

Rheumatology

1

1

105

C. Moriano

×

15

Publications

369

Citations

11

H-Index

YearCitations

Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

Monica Calderón-Goercke, J. Loricera, Vicente Aldasoro,

Seminars in Arthritis and Rheumatism

2019

105

Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice.

Monica Calderón-Goercke, Santos Castañeda, Vicente Aldasoro,

PubMed

2020

34

Tocilizumab in Behçet's disease with refractory ocular and/or neurological involvement: response according to different clinical phenotypes

Belén Atienza‐Mateo, E. Beltrán, Marisa Hernández‐Garfella,

Clinical and Experimental Rheumatology

2021

28

The presence of both HLA-DRB1[*]04:01 and HLA-B[*]15:01 increases the susceptibility to cranial and extracranial giant cell arteritis

D. Prieto-Peña, Sara Remuzgo‐Martínez, J. Gonzalo Ocejo‐Vinyals,

Clinical and Experimental Rheumatology

2021

26

Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients

Monica Calderón-Goercke, Santos Castañeda, Vicente Aldasoro,

Seminars in Arthritis and Rheumatism

2021

25

Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients

J. Loricera, Santos Castañeda, C. Moriano,

Therapeutic Advances in Musculoskeletal Disease

2022

24

Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients

Monica Calderón-Goercke, J. Loricera, C. Moriano,

Clinical and Experimental Rheumatology

2022

24

HLA association with the susceptibility to anti-synthetase syndrome

Sara Remuzgo‐Martínez, Belén Atienza‐Mateo, J. Gonzalo Ocejo‐Vinyals,

Joint Bone Spine

2020

19

Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association

D. Prieto-Peña, Sara Remuzgo‐Martínez, J. Gonzalo Ocejo‐Vinyals,

Seminars in Arthritis and Rheumatism

2020

17

The presence of both HLA-DRB1*04:01 and HLA-B*15:01 increases the susceptibility to cranial and extracranial giant cell arteritis.

D. Prieto-Peña, Sara Remuzgo‐Martínez, J. Gonzalo Ocejo‐Vinyals,

PubMed

2021

13

Page 1